| Pharmacy Legal Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
One Decade In and Counting: How 503B Outsourcing Facilities Are Finding Their Place in the Industry
Alexander Michael R, Combs Blinn E, Howard Brad
|
May/Jun 2025
Pg. 182-189
|
Current Problems of Pharmaceutical Compounding in Hungary
Dobson Szabolcs
|
Mar/Apr 2025
Pg. 96-103
|
Advertising and Marketing for Compounding Pharmacies: Many Shades of Grey
Hobbs Amanda F, Howard Brad
|
Mar/Apr 2025
Pg. 104-110
|
Navigating the Direct Importation of Active Pharmaceutical Ingredients: Compliance Considerations for Compounding Pharmacies
Byars Bradley S, Howard Brad
|
Jan/Feb 2025
Pg. 6-13
|
Best Practices When Compounding FDA-Approved Drugs Listed in Shortage
Alliance for Pharmacy Compounding
|
Jan/Feb 2025
Pg. 22-27
|
Compounded GLP-1 Drugs and Patient Adverse Events
Alliance for Pharmacy Compounding
|
Jan/Feb 2025
Pg. 33-36
|
Standard Operating Procedure for Assignment of Beyond-Use Dates
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 374-375
|
Drug Utilization Review: Our Patients Deserve Our Very Best
Jackson Kathleen
|
Nov/Dec 2023
Pg. 450-453
|
Considerations in Qualifying Critical Suppliers
Summers Amy
|
Nov/Dec 2023
Pg. 461-466
|
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 474-481
|
PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again!
Allen Loyd V Jr
|
May/Jun 2023
Pg. 180
|
Show Me the Science: A Perspective
Grzib Anthony
|
May/Jun 2023
Pg. 208-210
|
Quality Assurance: Compounding Record Audits for Error Prevention
Hawkins Jessica
|
May/Jun 2023
Pg. 211-217
|
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
|
Jan/Feb 2023
Pg. 22-23
|
The FDA is in a Hole. It Should Stop Digging.
Brunner Scott
|
Sep/Oct 2022
Pg. 396-398
|
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
|
Jul/Aug 2022
Pg. 309-315
|
PreScription: Standing in the Gap
Allen Loyd V Jr
|
May/Jun 2022
Pg. 180
|
Art of Pharmacy v. State
Standridge Rob
|
May/Jun 2022
Pg. 182-186
|
Compounding for Investigational and Clinical Studies
Allen Loyd V Jr
|
May/Jun 2022
Pg. 201-209
|
Three Things You Need to Know Right Now
Brunner Scott
|
May/Jun 2022
Pg. 211-213
|
PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 92
|
Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
|
Mar/Apr 2022
Pg. 100-109
|
Everything Old is New Again
Brunner Scott
|
Jan/Feb 2022
Pg. 30-32
|
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 356
|
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
|
Sep/Oct 2021
Pg. 358-362
|
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
|
Sep/Oct 2021
Pg. 364-371
|
Realities of Pharmaceutical Compounding in the Republic of Uzbekistan
Umarov Ulugbek, Zdoryk Oleksandr, Kolisnyk Sergii, Fatkhullaeva Muyussar
|
Sep/Oct 2021
Pg. 378-384
|
It's Time for a New Philosophy
Brunner Scott
|
Sep/Oct 2021
Pg. 386-387
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Sep/Oct 2021
Pg. 389-395
|
Expecting the Expected: Planning Considerations for Cleanroom Construction
Roberts Patricia A, Kroon Laura
|
Jul/Aug 2021
Pg. 276-281
|
Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists
Kiselova Olga, Maurina Baiba, Sidlovska Venta
|
Jul/Aug 2021
Pg. 288-295
|
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot
Brunner Scott
|
Jul/Aug 2021
Pg. 296-297
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Jul/Aug 2021
Pg. 298-302
|
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows
Brunner Scott
|
May/Jun 2021
Pg. 206-209
|
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 92
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2
DeRosa Angela
|
Jan/Feb 2021
Pg. 14-17
|
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg, Yoch Doug
|
Jan/Feb 2021
Pg. 18-23
|
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
|
Jan/Feb 2021
Pg. 24-28
|
Formulation and Pharmaceutical Evaluation of Extemporaneous α-arbutin Creams for the Treatment of Melasma
Teeranachaideekul Veerawat, Boonsongsawat Worrawee, Asanawittaya Waralee, Jintapattanakit Anchalee, Chantasart Doungdaw, Wongrakpanich Amaraporn
|
Jan/Feb 2021
Pg. 62-72
|
PreScription: The NASEM cBHT Report, Part 1
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 444
|
NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 446-448
|
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris, Greeson Nicole MH, Mixon William
|
Nov/Dec 2020
Pg. 451-458
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1
DeRosa Angela
|
Nov/Dec 2020
Pg. 466-470
|
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 356
|
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH, Mixon William, Allan W Chris
|
Sep/Oct 2020
Pg. 371-379
|
An Unconscionable, Unnecessary Fight
Brunner Scott
|
Sep/Oct 2020
Pg. 386-387
|
PreScription: COVID-19 and Compounding Pharmacists
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 268
|
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Greeson Nicole MH, Mixon William, Allan W Chris
|
Jul/Aug 2020
Pg. 270-276
|
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
|
Jul/Aug 2020
Pg. 296-297
|
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
|
Jul/Aug 2020
Pg. 322-326
|
U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk
Brunner Scott
|
May/Jun 2020
Pg. 198-199
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 92
|
A "North Star" for Pharmacy Compounders
Brunner Scott
|
Mar/Apr 2020
Pg. 110-113
|
PreScription: One Size Does Not Fit All!
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 4
|
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R, Radwick Allison
|
Jan/Feb 2020
Pg. 14-19
|
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk
Cabaleiro Joe
|
Jan/Feb 2020
Pg. 21-27
|
New and Improved!
Brunner Scott
|
Jan/Feb 2020
Pg. 28-29
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
PreScription: As Things Change….
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 444
|
How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
|
Nov/Dec 2019
Pg. 454-461
|
Are You Part of the Solution or Part of the Problem?
Brunner Scott
|
Nov/Dec 2019
Pg. 462-464
|
PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 356
|
Threading the Needle
Brunner Scott
|
Sep/Oct 2019
Pg. 383-385
|
Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future
Brunner Scott
|
Jul/Aug 2019
Pg. 294-296
|
How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
|
May/Jun 2019
Pg. 182-186
|
Can We Fix It?
Brunner Scott
|
May/Jun 2019
Pg. 208-209
|
PreScription: Compounding with Cannabidiol
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 92
|
Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
|
Mar/Apr 2019
Pg. 106-111
|
Patient Access Is a Patient Safety Issue
Pore David
|
Mar/Apr 2019
Pg. 120-121
|
Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 135-143
|
An Outlook on the European and Italian Rules to Guarantee Magistral Formulas
Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
|
Jan/Feb 2019
Pg. 6-12
|
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
|
Jan/Feb 2019
Pg. 32-33
|
Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 35-44
|
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
|
Jan/Feb 2019
Pg. 47-49
|
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
Martin Matt
|
Nov/Dec 2018
Pg. 475-478
|
PreScription: Updating Formulations
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 356
|
Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
|
Sep/Oct 2018
Pg. 358-366
|
Certification of Powder-containment Hoods for Nonsterile Compounding
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018
Pg. 369-384
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
|
Sep/Oct 2018
Pg. 401-404
|
Your Presence is Needed at Compounders on Capitol Hill!
Blankenship Cynthia
|
May/Jun 2018
Pg. 204-205
|
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 92
|
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
|
Mar/Apr 2018
Pg. 108-121
|
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing
Blankenship Cynthia
|
Mar/Apr 2018
Pg. 125-126
|
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
|
Mar/Apr 2018
Pg. 129-134
|
PreScription: 2017--Some Good Things Happened and Some Others
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 4
|
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 7-16
|
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives
Blankenship Cynthia
|
Jan/Feb 2018
Pg. 26-28
|
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 444
|
Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!
Blankenship Cynthia
|
Nov/Dec 2017
Pg. 468
|
Validation of the Technological Process of the Preparation "Milk by Vidal"
Savchenko LP, Mishchenko VA, Georgiyants VA
|
Nov/Dec 2017
Pg. 513-517
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 364-370
|
Documentation: Records and Reports
Akers Michael J
|
Sep/Oct 2017
Pg. 373-380
|
IACP Legislative/Regulatory Update
International Academy of Compounding Pharmacists
|
Sep/Oct 2017
Pg. 382-383
|
The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871
Rice Baylor
|
Jul/Aug 2017
Pg. 290-291
|
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
|
May/Jun 2017
Pg. 180
|
International Academy of Compounding Pharmacists Legislative/Regulatory Update
Rice Baylor
|
May/Jun 2017
Pg. 212-213
|
PreScription: Whatever Happened to Common Sense?
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 92
|
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
|
Mar/Apr 2017
Pg. 95-102
|
The International Academy of Compounding Pharmacists Introduces a New President
Rice Baylor
|
Mar/Apr 2017
Pg. 116-117
|
Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 118-124
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 127-130
|
PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 4
|
When to Compound Medications for Veterinary Patients
Forsythe Lauren Eichstadt
|
Jan/Feb 2017
Pg. 19-21
|
Why You Should Become an International Academy of Compounding Pharmacists Member
Gates Ernest P Jr
|
Jan/Feb 2017
Pg. 28
|
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
|
Nov/Dec 2016
Pg. 457-458
|
The "Lists": What Do They Mean?
Voliva John
|
Nov/Dec 2016
Pg. 477-479
|
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 485-493
|
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 356
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard!
Voliva John
|
Sep/Oct 2016
Pg. 377-378
|
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
IACP's 2016 Compounders on Capitol Hill Asks
|
Jul/Aug 2016
Pg. 294-296
|
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Akers Michael J
|
Jul/Aug 2016
Pg. 307-314
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
PreScription: Patient Access to Pharmaceuticals
Allen Loyd V Jr
|
May/Jun 2016
Pg. 180
|
Compounding in Nigeria
Alfred-Ugbenbo Deghinmotei, Zdoryk Oleksandr A, Georgiyants Victoriya A, Schnatz Rick
|
May/Jun 2016
Pg. 189-192
|
IACP Names Voliva Executive Vice President
McCrory Gary
|
May/Jun 2016
Pg. 194
|
PreScription: Compounding: A Changing Paradigm
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 92
|
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations
McCrory Gary
|
Mar/Apr 2016
Pg. 95-96
|
Microbial Identification in Pharmaceutical Compounding
Hyde Tiffany, Anstead James, Schade Lisa, Zellner James
|
Jan/Feb 2016
Pg. 13-18
|
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success
Pritchett Jon, Mixon William, O'Connell Kevin
|
Jan/Feb 2016
Pg. 29-36
|
PostScription: The Home Field Advantage
Cabaleiro Joe
|
Jan/Feb 2016
Pg. 86-87
|
PreScription: The Documented Past and the Exciting Future
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 442
|
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance
Miller David G
|
Nov/Dec 2015
Pg. 449-450
|
Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
|
Nov/Dec 2015
Pg. 453-463
|
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 487-488
|
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding
Miller David G
|
Sep/Oct 2015
Pg. 375
|
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015
Pg. 377-380
|
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 389-390
|
PostScription: Progress Report: Provider Status Continues to Gain Strength!
Menighan Thomas E
|
Sep/Oct 2015
Pg. 437
|
PreScription: Potpourri of Opinions…From Many
Allen Loyd V
|
Jul/Aug 2015
Pg. 266
|
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
|
Jul/Aug 2015
Pg. 303-305
|
Basics of Compounding: The "Negative" List
Allen Loyd V
|
Jul/Aug 2015
Pg. 311-313
|
IACP Says: "Fix DQSA"
Miller David
|
May/Jun 2015
Pg. 212
|
Quality Assurance and Quality Control, Part 2
Akers Michael J
|
May/Jun 2015
Pg. 215-221
|
PostScription: Opportunities to Change the Pharmacy Landscape
Menighan Thomas E
|
May/Jun 2015
Pg. 271
|
New England Compounding Center Indictment
Cabaleiro Joe
|
Mar/Apr 2015
Pg. 94-102
|
Standing Together Fixing the Drug Quality and Security Act
Miller David G
|
Mar/Apr 2015
Pg. 104-106
|
Standarized Compounding: The Importance of Doing it the Same Way Every Time
Dillon L Rad
|
Mar/Apr 2015
Pg. 109-112
|
PreScription: 2014 in Review
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 4
|
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Grilli Anthony, Sutton Scott
|
Jan/Feb 2015
Pg. 30-37
|
Basics of Sterile Compounding: Aseptic Processing
Akers Michael J
|
Jan/Feb 2015
Pg. 49-56
|
Basics of Compounding: The Revised "Not to Compound List"
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 57-58
|
PostScription: Pharmacists Advancing Toward Provider Status
Menighan Thomas E
|
Jan/Feb 2015
Pg. 86-87
|
Compounding Legislation: Focus Shifts to States
Miller David G
|
Nov/Dec 2014
Pg. 470-472
|
PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future
Cabaleiro Joe
|
Nov/Dec 2014
Pg. 526-527
|
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
|
Sep/Oct 2014
Pg. 379-380
|
Compounding Practices in a Portuguese Community Pharmacy
Reis Maria, Carvalho Maria, Rodrigues Angelo
|
Sep/Oct 2014
Pg. 392-395
|
PostScription: The Future of Veterinary Compounding
Jordan Dinah G
|
Sep/Oct 2014
Pg. 438-439
|
PreScription: Challenging Times
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 268
|
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain, Sully Andrew, Anthenat Bruce
|
Jul/Aug 2014
Pg. 270-276
|
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India
Kumar Anuj, Madan Anil K
|
Jul/Aug 2014
Pg. 293-300
|
400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill
Miller David G
|
Jul/Aug 2014
Pg. 302
|
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014
Pg. 305-310
|
PreScription: Déjà Vu All Over Again
Allen Loyd V Jr
|
May/Jun 2014
Pg. 180
|
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
|
May/Jun 2014
Pg. 208
|
PreScription: Standards vs Opinions
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 92
|
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Timko Robert J, Crooker Philip EM
|
Mar/Apr 2014
Pg. 101-111
|
Compounding Practices in Iran
Goodarzi Navid, Niknam Somayeh, Akbarzadeh Tahmineh, Gholami Kheirollah
|
Mar/Apr 2014
Pg. 112-116
|
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities
Miller David G
|
Mar/Apr 2014
Pg. 117-118
|
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 4
|
Good Enough for America
Worthen Dennis B
|
Jan/Feb 2014
Pg. 20-29
|
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Miller David G
|
Jan/Feb 2014
Pg. 35-36
|
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 477-479
|
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now?
Miller David G
|
Nov/Dec 2013
Pg. 480-481
|
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013
Pg. 485-489
|
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 356
|
Compounding Pharmacies: Before and After an Inspection
Kulkarni Darshan, Ricketts Samantha
|
Sep/Oct 2013
Pg. 358-362
|
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
|
Sep/Oct 2013
Pg. 364-368
|
2013 State Compounding Legislation Tracker Updated: August 12, 2013
Miller David G
|
Sep/Oct 2013
Pg. 375-378
|
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 439
|
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
|
Jul/Aug 2013
Pg. 283-288
|
Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover
Rizo Mike
|
Jul/Aug 2013
Pg. 290-293
|
International Academy of Compounding Pharmacists Legislative/Regulatory Update
Miller David G
|
Jul/Aug 2013
Pg. 302-304
|
PostScription: Traditional vs Nontraditional Pharmacy
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 351
|
PreScription: Compounding for Drug Shortages
Allen Loyd V Jr
|
May/Jun 2013
Pg. 180
|
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Mixon Bill, Nain John
|
May/Jun 2013
Pg. 182-190
|
Decontamination Technology: The Missing Element
Rahe Hank
|
May/Jun 2013
Pg. 193-199
|
International Academy of Compounding Pharmacists' Legislative/Regulatory Update
Miller David G
|
May/Jun 2013
Pg. 206
|
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Allen Loyd V Jr
|
May/Jun 2013
Pg. 210-219
|
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
May/Jun 2013
Pg. 238-246
|
PreScription: Pharmacy Committees
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 92
|
Compounding in Ukraine
Zdoryk Oleksandr A, Georgiyants Victoriya A, Gryzodub Oleksandr I, Schnatz Rick
|
Mar/Apr 2013
Pg. 124-127
|
International Academy of Compounding Pharmacists Legislative/Regulatory Update
Miller David G
|
Mar/Apr 2013
Pg. 128
|
PreScription: Looking for Solutions
Menighan Thomas E
|
Jan/Feb 2013
Pg. 4
|
Pediatric Health Care: An Introduction
Williams LaVonn A
|
Jan/Feb 2013
Pg. 6-8
|
International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives
Miller David G
|
Jan/Feb 2013
Pg. 48-49
|
PostScription: GMPs and GCPs: A Topical Comparison
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 87
|
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Pore R David
|
Nov/Dec 2012
Pg. 446-450
|
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
|
Nov/Dec 2012
Pg. 456-460
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
Nov/Dec 2012
Pg. 476-478
|
Quality Control: Analytical Methods. Certificates of Analysis, Part 1
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 486-488
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 490-496
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
Sep/Oct 2012
Pg. 382-384
|
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 294-298
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
Jul/Aug 2012
Pg. 300-302
View Sample |
Selection of Color Additives: A Regulatory View
Kumar Anuj, Dureja Harish, Madan Anil K
|
Jul/Aug 2012
Pg. 304-309
|
PreScription: You're On Your Own
Allen Loyd V Jr
|
May/Jun 2012
Pg. 180
|
PreScription: Working in Handcuffs
Menighan Thomas E
|
May/Jun 2012
Pg. 180
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
May/Jun 2012
Pg. 220-222
View Sample |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification
Allen Loyd V Jr
|
May/Jun 2012
Pg. 230-234
|
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy
Miller David G
|
Mar/Apr 2012
Pg. 94-96
View Sample |
Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, do Carmo Garcez Maria
|
Mar/Apr 2012
Pg. 98-102
|
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone
Cabaleiro Joe
|
Jan/Feb 2012
Pg. 86-87
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
Jan/Feb 2012
Pg. 50-52
View Sample |
PreScription: Compounding: Keeping Elephants Our of Our Mouseholes
Menighan Thomas E
|
Nov/Dec 2011
Pg. 444
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
Nov/Dec 2011
Pg. 471-472
View Sample |
The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire
Miller David G
|
Nov/Dec 2011
Pg. 474-479
View Sample |
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
|
Nov/Dec 2011
Pg. 526-527
|
PreScription: Third-party Inequities and Discrimination
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 356
|
Natural Tragedies: Planning for Disasters and Emergencies
Williams LaVonn A
|
Sep/Oct 2011
Pg. 368-371
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David
|
Sep/Oct 2011
Pg. 382-384
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 408-414
|
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy
Mixon William, Wood Adam P, Low Jennifer, Homan Linda
|
Jul/Aug 2011
Pg. 278-284
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David
|
Jul/Aug 2011
Pg. 286-288
|
PreScription: Greed Does Not Pay! Makena, Lucentis, and Others
Allen Loyd V Jr
|
May/Jun 2011
Pg. 180
|
PreScription: Making Things Right--Or Not?
Menighan Thomas E
|
May/Jun 2011
Pg. 180
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David
|
May/Jun 2011
Pg. 218-221
|
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Schnatz Rick, Hernandex-Cardoso Antonio
|
May/Jun 2011
Pg. 224-232
|
PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 92
|
PreScription: Compounding with Manufactured Products
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 448
|
Home Infusion: Overcoming the Barriers to Entry
Franklin David M
|
Nov/Dec 2010
Pg. 450-455
|
PreScription: Compounding Veterinary Products: Needed but Problematic
Menighan Thomas E
|
Sep/Oct 2010
Pg. 358
|
Home Infusion Accreditation: Another Quality Recognition Branding Tool
Canally Sandra C
|
Sep/Oct 2010
Pg. 360-364
|
PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 268
|
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals
Menighan Thomas E
|
Jul/Aug 2010
Pg. 268
|
PreScription: Healthcare Reform Is Not All That Is Happening in Washington
Menighan Thomas E
|
May/Jun 2010
Pg. 180
|
PostScription: Healthcare Reform and Compounding Issues
Levesque Paul T
|
May/Jun 2010
Pg. 262-263
|
Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs
Burke John, Hill Jeff
|
Mar/Apr 2010
Pg. 131-133
|
PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort?
Allen Loyd V Jr, Burger Mark
|
Mar/Apr 2010
Pg. 174-175
|
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria
|
Nov/Dec 2009
Pg. 532-536
|
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding
McElhiney Linda F
|
Nov/Dec 2009
Pg. 525-530
|
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Gilbert John A
|
Sep/Oct 2009
Pg. 400-403
|
PostScription: Setting up a National System of Compounding Pharmacies: An Introduction
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria
|
Sep/Oct 2009
Pg. 447
|
PostScription: Compounding Pharmacy in Puerto Rico
Lopez Marisol
|
Jul/Aug 2009
Pg. 350-351
|
PreScription: Electronic Prescribing
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 92
|
PostScription: Compounding in Argentina
Naddeo Aldo Mario
|
Mar/Apr 2009
Pg. 175
|
PreScription: A New Start: What Will 2009 Bring?
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 4
|
PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective
Guedes de Souza Hugo, do Carmo Garcez Maria, Pinheiro Vanessa A
|
Jan/Feb 2009
Pg. 87-88
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2009
Pg. 56-62
|
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials
Storme-Paris Isabelle, Storme Thomas, Thauvin Maxime, Brion Francoise, Chaminade Pierre, Rieutord Andre
|
Jan/Feb 2009
Pg. 81-86
|
Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information
Neal Amy S, DeVeau Ian, Schnatz Rick G
|
Sep/Oct 2008
Pg. 405-409
|
Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship
Kirk Loren Madden
|
Sep/Oct 2008
Pg. 410-413
|
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Sep/Oct 2008
Pg. 414-418
|
Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered?
Baker Kenneth R
|
Sep/Oct 2008
Pg. 420-424
|
Prescription: Is "Globalization" a Good Idea?
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 474
|
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Nov/Dec 2008
Pg. 508-513
|
Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where
Baker Kenneth R
|
Nov/Dec 2008
Pg. 514-523
|
PostScription: Supporting Compounding Around the World
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 565
|
PreScription: First Estriol, Then What?
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 284
|
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
|
Jul/Aug 2008
Pg. 365-367
|
PostScription: It Is Not Just What You Say…But How You Say It!
Reed-Kane Dana
|
Jul/Aug 2008
Pg. 375
|
Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
|
Jul/Aug 2008
Pg. 286-292
|
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Jul/Aug 2008
Pg. 329-333
|
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization
Westrick Salisa C, Felkey Bill G
|
Jul/Aug 2008
Pg. 334-337
|
PreScription: Pain!
Allen Loyd V Jr
|
May/Jun 2008
Pg. 180
|
Litigating the Legality of Compounding: The Medical Center Pharmacy Case
Gibbs Jeffrey N
|
May/Jun 2008
Pg. 238-241
|
Current Compounding Practices in Europe
Carvalho Maria, Tuleu Catherine, Taylor Kevin MG
|
Mar/Apr 2008
Pg. 94-99
|
Compounding Around the World
Vail Jane
|
Mar/Apr 2008
Pg. 102-115
|
Establishing a Quality-Assurance Program for Hospital Compounding
McElhiney Linda F
|
Mar/Apr 2008
Pg. 116-120
|
Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J, Ahlgrimm Maria
|
Mar/Apr 2008
Pg. 122-127
|
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care
Murry Tom
|
Mar/Apr 2008
Pg. 174-175
|
PreScription: Year Number 12…And Still Much Work to Do
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 4
|
Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
|
Jan/Feb 2008
Pg. 38-47
View Sample |
Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 63
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2008
Pg. 54-60
|
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Jan/Feb 2008
Pg. 74-82
|
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study
Peters Gregory F, McKeon Marghi R, Nerbun Richard G
|
Nov/Dec 2007
Pg. 450-470
|
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds
Trusley Craig
|
Nov/Dec 2007
Pg. 487-490
|
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 438-439
|
PreScription: Bias, NAMS, and HRT
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 266
|
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature
Paoletti Jim, Kaul Monica, Kloesel Lawson G
|
Jul/Aug 2007
Pg. 269-272
|
Premarin: The Intriguing History of a Controversial Drug
Vance Dwight A
|
Jul/Aug 2007
Pg. 282-286
|
The Politics of Hormone Replacement Therapy
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 278-281
|
Quality-control Analytical Methods: Logbooks and Documentation Forms
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 306-311
|
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2007
Pg. 314-323
|
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration
Kupiec Tom, Kemp Jesse
|
Jul/Aug 2007
Pg. 326-327
|
Statistical Analysis of Barrier Isolator/Glovebox Glove Failure
Park Young H, Pines E, Ofouku M, Cournoyer ME
|
Jul/Aug 2007
Pg. 338-346
|
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 350-351
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007
Pg. 220-225
|
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2007
Pg. 230-236
|
Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form
Allen Loyd V Jr
|
May/Jun 2007
Pg. 240-241
|
PostScription: Lobbying: How It Affects Compounding
Rock Jim
|
May/Jun 2007
Pg. 262-263
|
PreScription: State or Federal Control of Pharmacy Practice
Allen Loyd V Jr
|
May/Jun 2007
Pg. 178
|
PreScription: Putting the Science Back into Pharmacy
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 92
|
Certified Diabetes Educator: A Credential for Compounding Pharmacists
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 113-115
|
Records and Record-Keeping for the Hospital Compounding Pharmacist
McElhiney Linda F
|
Mar/Apr 2007
Pg. 138-143
|
PreScription: IJPC: The Next 10 Years
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 2
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
Jan/Feb 2007
Pg. 5-8
|
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Anderson Derick
|
Jan/Feb 2007
Pg. 56-58
|
Pharmacogenomics: The End of Trial-and-Error Medicine?
Vail Jane
|
Jan/Feb 2007
Pg. 59-65
|
PostScription: Challenges Facing an Analytical Laboratory
Kupiec Thomas C
|
Nov/Dec 2006
Pg. 479-480
|
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Nov/Dec 2006
Pg. 462-468
|
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 446-448
|
Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
|
Sep/Oct 2006
Pg. 324-328
|
Education, Training, and Evaluation of Hospital Compounding Personnel
McElhiney Linda F
|
Sep/Oct 2006
Pg. 361-368
|
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 377-379
|
PreScription: Standards, Legal Standards, and Accreditation
|
May/Jun 2006
Pg. 162
|
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana, Kirshbaum Karen
|
May/Jun 2006
Pg. 165-171
|
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna, Jones William, Stephenson Douglas M M
|
May/Jun 2006
Pg. 175-183
|
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006
Pg. 202-204
|
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2
Wagner James T
|
May/Jun 2006
Pg. 208-211
|
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk!
Mason Dave
|
May/Jun 2006
Pg. 240
|
PreScription: The Squeaky Wheel Gets the Grease!
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 82
|
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist
Jeffrey Megan
|
Mar/Apr 2006
Pg. 113-119
|
Pharmaceutical Legislation: An Historical Perspective
Worthen Dennis B
|
Jan/Feb 2006
Pg. 20-28
|
Pharmacy Compounding Urban Legends
Kastango Eric S
|
Jan/Feb 2006
Pg. 32-34
|
Prescription: Pediatric Formulation Initiatives
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 410
|
Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America
Reed-Kane Dana
|
Sep/Oct 2005
Pg. 332-333
|
Compounding: A Well-established Practice in 1938
Houck Larry K
|
Sep/Oct 2005
Pg. 364-367
|
Local Ventilation for Safe Containment in the Pharmaceutical Industry
Walters Douglas B, Ryan Ray
|
Jul/Aug 2005
Pg. 293-298
|
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products
Wagner James T
|
Jul/Aug 2005
Pg. 284-290
|
Survey of State Veterinary Compounding Laws and Regulations
Goodrum Jennifer
|
May/Jun 2005
Pg. 209-211
|
PostScription: AVMA's Position on Compounding for Animals
Riddell M Gatz
|
May/Jun 2005
Pg. 247-248
|
Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer
Reed-Kane Dana
|
Mar/Apr 2005
Pg. 93-94
|
Standard Operating Procedure: SOP Master Book--Maintenance
Allen Loyd V Jr
|
Mar/Apr 2005
Pg. 145
|
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Newton David W
|
Mar/Apr 2005
Pg. 127-130
|
Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations
Kupiec Thomas C
|
Mar/Apr 2005
Pg. 136-138
|
PostScription: Experts Everywhere
Rahe Hank
|
Mar/Apr 2005
Pg. 167
|
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")
Allen Loyd V Jr, Ashworth Lisa D
|
Jan/Feb 2005
Pg. 44-46
|
Is Veterinary Compounding Illegal Under Federal Law?
Gibbs Jeffrey N
|
Nov/Dec 2004
Pg. 449-450
|
PostScription: Your voice is important to the future of pharmacy
Tosh Erik
|
Sep/Oct 2004
Pg. 407
|
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W, Trissel Lawrence A
|
Jul/Aug 2004
Pg. 251-263
|
PostScription: Cleanroom Standards
Fitzpatrick Mike, Goldstein Ken
|
Mar/Apr 2004
Pg. 160
|
PostScription: The Wedgewood Case: What It Means for Pharmacies
Gibbs Jeffrey N, Wasserstein Jeffrey N
|
Jan/Feb 2004
Pg. 79-80
|
PreScription: Take Care with Terminology for Altered- and Slow-release Formulations
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 418
|
PostScription: Changing Pharmacy Regulations Could Affect US Compounders
Downing Pat, Roberson Kim
|
Nov/Dec 2003
Pg. 495
|
Application of USP-NF Standards to Pharmacy Compounding
Bormel Gail, Valentine Joseph G, Williams Roger L
|
Sep/Oct 2003
Pg. 361-363
View Sample |
HIPAA Privacy and Security for Providers: The Basics
Kuruc Jullian H
|
Jul/Aug 2003
Pg. 277-279
|
Containment of Hazardous Particulates in the Compounding Pharmacy
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 281-285
|
Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics?
McElhiney Linda F
|
Jul/Aug 2003
Pg. 320
|
Legal & Ethical Issues for Pharmacy Websites
King LD, Brashares Jennifer
|
Mar/Apr 2003
Pg. 88-92
|
Regulatory and Operational Issues of Founding a Compounding Pharmacy
Smith Lisa K
|
Nov/Dec 2002
Pg. 434-437
|
Medications Discontinued in the United States
Ashworth Lisa D
|
Nov/Dec 2002
Pg. 441-442
|
Compounding and the Courts
Gibbs Jeffrey N, Wasserstein Jeffrey N
|
Jul/Aug 2002
Pg. 263-266
|
Facilities and Procedures for Compounding Hazardous Drugs
Rahe Hank
|
Jul/Aug 2002
Pg. 267-270
|
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Kramer Mark A, Grilley Bambi J
|
Jul/Aug 2002
Pg. 271-273
|
Legal Issues: Technicians in the Compounding Pharmacy Practice
Fix Jennifer Taylor
|
Jul/Aug 2002
Pg. 274-275
|
Medications Discontinued in the United States
Ashworth Lisa D
|
Jul/Aug 2002
Pg. 286-287
|
Medications Discontinued in the United States
Ashworth Lisa D
|
May/Jun 2002
Pg. 193
|
Medications Discontinued in the United States
Ashworth Lisa D
|
Mar/Apr 2002
Pg. 123
|
Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory
Ashworth Lisa D, Gordon Dana, Leiter Charles W, Snow Whit
|
Mar/Apr 2002
Pg. 149-150
|
Compounding with Controlled Substances
Whalen Mary Kate
|
Jan/Feb 2002
Pg. 8-10
|
The Problem of Drug Diversion
Burke John J
|
Jan/Feb 2002
Pg. 11-12
|
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective
Vail Jane
|
Jan/Feb 2002
Pg. 13-15
|
PostScription: Regulatory Uncertainty Requires Professional Responsibility
King LD
|
Jan/Feb 2002
Pg. 80
|
Compounding Issues and Accreditation Agencies
Petroff Barb
|
Jul/Aug 2001
Pg. 273-274
|
The American Veterinary Medical Association Compounding Position Statement
Davidson Gigi S
|
May/Jun 2001
Pg. 216-217
|
Establishing and Maintaining a Compounding Pharmacy Reference Library
Allen Loyd V Jr
|
May/Jun 2001
Pg. 226-227
|
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding
Chan Debora Schotik
|
Mar/Apr 2001
Pg. 97-100
|
Drugs Banned for Use in Food Animals: An Explanation
Davidson Gigi S
|
Mar/Apr 2001
Pg. 101-103
|
From Wagon-Era Paregoric to Computer-Era Herbals
Newton David W
|
Mar/Apr 2001
Pg. 112-115
|
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing
Douglass Kate, Kastango Eric S
|
Mar/Apr 2001
Pg. 140-144
|
Assignment of a Beyond-Use Date for Compounded Preparations
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 474-475
|
Compounding Using Hazardous Drugs
Lau Kellie
|
Jul/Aug 2000
Pg. 261-263
|
Compounding OTC Drugs: A Legal Perspective
Gibbs Jeffrey N, Mazan Kate Duffy
|
May/Jun 2000
Pg. 180-181
|
Pharmacy Licensure Requirements
Allen Loyd V Jr
|
May/Jun 2000
Pg. 186
|
The Future of Compounding: An Industry Perspective
Capps Shelly, Winckler Susan C, Anthony Calvin J, Halperin Jerome A
|
May/Jun 2000
Pg. 204-205
|
Assignment of Beyond-Use Dates
Allen Loyd V Jr
|
May/Jun 2000
Pg. 222
|
Analytical Testing of Extemporaneously Compounded Preparations
Kupiec Thomas C
|
Mar/Apr 2000
Pg. 105-107
|
When Problem Audits Strike
Heckman H Edward
|
Nov/Dec 1999
Pg. 458-459
|
When is Compounding for Animals Legal?
Siegner A Wes Jr
|
May/Jun 1999
Pg. 188-191
|
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 126-127
|
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 25-29
|
Opioids for Noncancer Pain: From Controversy to Consensus
Spanos Alan
|
Mar/Apr 1998
Pg. 106-108
|
Firing an Employee - Without Getting Burned
Davis Jeanie Lerche
|
Mar/Apr 1998
Pg. 130-133
|
FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding
Letendre William R
|
Nov/Dec 1997
Pg. 399-403
|
Aspirin in Chloroform (Chloroform Banned in US)
Allen Loyd V Jr
|
Nov/Dec 1997
Pg. 407
|
The Decision to Compound
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 71-74
|
The Compounding Pharmacist
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 73-74
|
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 75-77
|
| Return to Top |
